References and Recommended Reading
Gregoratos G: Permanent pacemakers in older persons. J Am Geriatr Soc 1999, 47:1125–1135.
Benditt DG, Fahy GJ, Lurie KG, et al.: Pharmacotherapy of neurally mediated syncope. Circulation 1999, 100:1242–1248. A comprehensive review of modern pharmacotherapeutic options in use for the therapy of vasovagal and other forms of syncope.
Bhaumick SK, Morgan S, Mondal BK: Oral disopyramide in the treatment of recurrent neurocardiogenic syncope. Int J Clin Pract 1997, 51:342.
Sra J, Maglio C, Biehl M, et al.: Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol 1997, 8:42–46.
Benditt DG, Sutton R, Gammage M, et al.: “Rate-drop response”. cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group. J Interv Card Electrophysiol 1999, 3:27–33. Retrospective trial of 24 patients with vasovagal syncope. An excellent description of the “rate-drop” feature.
Connolly SJ, Sheldon R, Roberts RS, Gent M: The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999, 33:16–20. A trial planning to enroll close to 300 patients which was terminated early due to the overwhelming benefit seen in the treatment arm.
Sutton R, Brignole M, Menozzi C, et al.: Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000, 102:294–299.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dresing, T.J., Wilkoff, B.L. Bradyarrhythmias. Curr Treat Options Cardio Med 3, 291–298 (2001). https://doi.org/10.1007/s11936-001-0091-9
Issue Date:
DOI: https://doi.org/10.1007/s11936-001-0091-9